BioPharma Revolution: Exploring the Nexus of Biotechnology and Pharmacology PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download BioPharma Revolution: Exploring the Nexus of Biotechnology and Pharmacology PDF full book. Access full book title BioPharma Revolution: Exploring the Nexus of Biotechnology and Pharmacology by Aliasghar Tabatabaei Mohammadi. Download full books in PDF and EPUB format.
Author: Aliasghar Tabatabaei Mohammadi
Publisher: Nobel Sciences
ISBN:
Category : Medical
Languages : en
Pages : 351
Get Book Here
Book Description
Chapters Chapter 1: Exploring the Nexus of Biotechnology and Psychopharmacology to treat mental disorder by concentration on substance use disorder Chapter 2: Biotechnology and Pharmacology: A Powerful Confluence of Science and Medicine Chapter 3: Bioinformatics and Computational Biology: Unraveling Biological Complexity Chapter 4: Bioprocessing and Biomanufacturing: Engineering the Future of Drug Production Chapter 5: Targeted Drug Delivery: Innovations in Nanotechnology and Drug Carriers Chapter 6: Biomarkers: The Key to Precision Diagnosis and Treatment Chapter 7: Regenerative Medicine: Harnessing the Power of Cellular and Tissue Engineering Chapter 8: Gene Editing and CRISPR Technology: Rewriting the Possibilities in Disease Treatment Chapter 9: Monoclonal Antibodies: Engineered Warriors against Disease Chapter 10: Unlocking the Genetic Code: Genomics and Personalized Medicine
Author: Aliasghar Tabatabaei Mohammadi
Publisher: Nobel Sciences
ISBN:
Category : Medical
Languages : en
Pages : 351
Get Book Here
Book Description
Chapters Chapter 1: Exploring the Nexus of Biotechnology and Psychopharmacology to treat mental disorder by concentration on substance use disorder Chapter 2: Biotechnology and Pharmacology: A Powerful Confluence of Science and Medicine Chapter 3: Bioinformatics and Computational Biology: Unraveling Biological Complexity Chapter 4: Bioprocessing and Biomanufacturing: Engineering the Future of Drug Production Chapter 5: Targeted Drug Delivery: Innovations in Nanotechnology and Drug Carriers Chapter 6: Biomarkers: The Key to Precision Diagnosis and Treatment Chapter 7: Regenerative Medicine: Harnessing the Power of Cellular and Tissue Engineering Chapter 8: Gene Editing and CRISPR Technology: Rewriting the Possibilities in Disease Treatment Chapter 9: Monoclonal Antibodies: Engineered Warriors against Disease Chapter 10: Unlocking the Genetic Code: Genomics and Personalized Medicine
Author: Adriana Petryna
Publisher: Duke University Press
ISBN: 9780822337416
Category : Business & Economics
Languages : en
Pages : 314
Get Book Here
Book Description
DIVAnthropological study of the globalization of pharmaceuticals and its effects on local cultures, health, and economics./div
Author: Franco Malerba
Publisher: Cambridge University Press
ISBN: 1139454161
Category : Business & Economics
Languages : en
Pages : 537
Get Book Here
Book Description
This volume provides a novel way of examining innovation in sectors by proposing the framework of sectoral systems of innovation. It analyses the innovation process, the factors affecting innovation, the changing boundaries and transformation of sectors, and the determinants of the innovation performance of firms and countries in different sectors.
Author: Mihail C. Roco
Publisher: Springer Science & Business Media
ISBN: 9401703590
Category : Technology & Engineering
Languages : en
Pages : 477
Get Book Here
Book Description
M. C. Roco and W.S. Bainbridge In the early decades of the 21st century, concentrated efforts can unify science based on the unity of nature, thereby advancing the combination of nanotechnology, biotechnology, information technology, and new technologies based in cognitive science. With proper attention to ethical issues and societal needs, converging in human abilities, societal technologies could achieve a tremendous improvement outcomes, the nation's productivity, and the quality of life. This is a broad, cross cutting, emerging and timely opportunity of interest to individuals, society and humanity in the long term. The phrase "convergent technologies" refers to the synergistic combination of four major "NBIC" (nano-bio-info-cogno) provinces of science and technology, each of which is currently progressing at a rapid rate: (a) nanoscience and nanotechnology; (b) biotechnology and biomedicine, including genetic engineering; (c) information technology, including advanced computing and communications; (d) cognitive science, including cognitive neuroscience. Timely and Broad Opportunity. Convergence of diverse technologies is based on material unity at the nanoscale and on technology integration from that scale.
Author: Alfonso Gambardella
Publisher:
ISBN: 9780756726324
Category : Business & Economics
Languages : en
Pages : 103
Get Book Here
Book Description
Pharmaceuticals is a large, high-growth, globalized, & innovation intensive industry. Pharmaceuticals has long been a stronghold of the European industry, & it still provides by far the largest contribution to the European trade balance in high-technology, R&D intensive sectors. However, it is now a diffused perception that the European pharmaceutical industry is losing ground vis-a-vis the U.S. Against this background, the Report examines the competitive position of the European pharmaceutical companies & industries, & compares them with the pharmaceutical companies & industries in other parts of the world, particularly the U.S. Charts, tables & graphs.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309487811
Category : Medical
Languages : en
Pages : 69
Get Book Here
Book Description
On July 30-31, 2018, the National Academies of Sciences, Engineering, and Medicine held a workshop titled Continuous Manufacturing for the Modernization of Pharmaceutical Production. This workshop discussed the business and regulatory concerns associated with adopting continuous manufacturing techniques to produce biologics such as enzymes, monoclonal antibodies, and vaccines. The participants also discussed specific challenges for integration across the manufacturing system, including upstream and downstream processes, analytical techniques, and drug product development. The workshop addressed these challenges broadly across the biologics domain but focused particularly on drug categories of greatest FDA and industrial interest such as monoclonal antibodies and vaccines. This publication summarizes the presentations and discussions from the workshop.
Author: Henry Etzkowitz
Publisher: Routledge
ISBN: 1135925275
Category : Business & Economics
Languages : en
Pages : 299
Get Book Here
Book Description
A Triple Helix of university-industry-government interactions is the key to innovation in increasingly knowledge-based societies. As the creation, dissemination, and utilization of knowledge moves from the periphery to the center of industrial production and governance, the concept of innovation, in product and process, is itself being transformed. In its place is a new sense of 'innovation in innovation' - the restructuring and enhancement of the organizational arrangements and incentives that foster innovation. This triple helix intersection of relatively independent institutional spheres generates hybrid organizations such as technology transfer offices in universities, firms, and government research labs and business and financial support institutions such as angel networks and venture capital for new technology-based firms that are increasingly developing around the world. The Triple Helix describes this new innovation model and assists students, researchers, and policymakers in addressing such questions as: How do we enhance the role of universities in regional economic and social development? How can governments, at all levels, encourage citizens to take an active role in promoting innovation in innovation and, conversely, how can citizens so encourage their governments? How can firms collaborate with each other and with universities and government to become more innovative? What are the key elements and challenges to reaching these goals?
Author: John Braithwaite
Publisher: Routledge
ISBN: 1135072906
Category : Social Science
Languages : en
Pages : 451
Get Book Here
Book Description
First published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior executives of pharmaceutical companies in the United States, the United Kingdom, Australia, Mexico and Guatemala, the book is a major study of white-collar crime. Written in the 1980s, it covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs. The author considers the implications of his findings for a range of strategies to control corporate crime, nationally and internationally.
Author: Minnesota. Department of Employment and Economic Development
Publisher: Minnesota Department of Employment and Economic Development
ISBN:
Category : Business & Economics
Languages : en
Pages : 260
Get Book Here
Book Description
Author: Kean Birch
Publisher: MIT Press
ISBN: 0262539179
Category : Business & Economics
Languages : en
Pages : 339
Get Book Here
Book Description
How the asset—anything that can be controlled, traded, and capitalized as a revenue stream—has become the primary basis of technoscientific capitalism. In this book, scholars from a range of disciplines argue that the asset—meaning anything that can be controlled, traded, and capitalized as a revenue stream—has become the primary basis of technoscientific capitalism. An asset can be an object or an experience, a sum of money or a life form, a patent or a bodily function. A process of assetization prevails, imposing investment and return as the key rationale, and overtaking commodification and its speculative logic. Although assets can be bought and sold, the point is to get a durable economic rent from them rather than make a killing on the market. Assetization examines how assets are constructed and how a variety of things can be turned into assets, analyzing the interests, activities, skills, organizations, and relations entangled in this process. The contributors consider the assetization of knowledge, including patents, personal data, and biomedical innovation; of infrastructure, including railways and energy; of nature, including mineral deposits, agricultural seeds, and “natural capital”; and of publics, including such public goods as higher education and “monetizable social ills.” Taken together, the chapters show the usefulness of assetization as an analytical tool and as an element in the critique of capitalism. Contributors Thomas Beauvisage, Kean Birch, Veit Braun, Natalia Buier, Béatrice Cointe, Paul Robert Gilbert, Hyo Yoon Kang, Les Levidow, Kevin Mellet, Sveta Milyaeva, Fabian Muniesa, Alain Nadaï, Daniel Neyland, Victor Roy, James W. Williams
